Triple-seronegative myasthenia gravis: clinical and epidemiological characteristics

Abstract

Background Myasthenia gravis (MG) is an autoimmune disease usually caused by antibodies against the acetylcholine receptor (AChR-Abs), muscle-specific tyrosine kinase (MuSK-Abs), or low-density lipoprotein receptor-related protein 4 (LRP4-Abs). However, there are MG patients who do not have these antibodies and are thus said to have triple-seronegative (triple-SN) MG.

Keywords

• Myasthenia Gravis
• Antibodies
• Receptors, Cholinergic
• Acetylcholine
• Miastenia Gravis
• Anticorpos
• Receptores Colinérgicos
• Acetilcolina